Gemcitabine and vinorelbine followed by docetaxel in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial of nonplatinum sequential triplet combination chemotherapy (JMTO LC00-02)

To evaluate the efficacy and toxicity of the sequential nonplatinum combination chemotherapy consisting of gemcitabine (GEM) and vinorelbine (VNR) followed by docetaxel (DOC) in patients with advanced non-small-cell lung cancer (NSCLC), we conducted the multiinstitutional phase II study. A total of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hosoe, S, Komuta, K, Shibata, K, Harada, H, Iwamoto, Y, Ohsaki, Y, Morioka, T, Origasa, H, Fukushima, M, Furuse, K, Kawahara, M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2003
Assuntos:
Clinical
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2747544/
https://ncbi.nlm.nih.gov/pubmed/12569374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600723
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados